Patricia Gripka Moorman
Professor Emeritus in Family Medicine and Community Health
Dr. Moorman's research focuses on the epidemiology of women's health issues. Her work includes research on ovarian cancer, breast cancer and hysterectomy. Areas of particular interest include disparities in cancer risk factors and outcomes and the effects of hysterectomy on ovarian function. As part of the Duke Evidence Synthesis group, she has also been involved in systematic reviews and meta-analyses related to ovarian cancer, breast cancer and infertility.
Current Appointments & Affiliations
- Professor Emeritus in Family Medicine and Community Health, Family Medicine and Community Health, Prevention Research, Family Medicine and Community Health 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2000
Contact Information
- 2424 Erwin Road, Suite 602, Durham, NC 27705
- Box 2715 Med Ctr, Durham, NC 27710
-
patricia.moorman@duke.edu
(919) 681-4557
- Background
-
Education, Training, & Certifications
- Ph.D., University of North Carolina - Chapel Hill 1993
- M.S.P.H., University of North Carolina - Chapel Hill 1989
-
Previous Appointments & Affiliations
- Professor in Family Medicine and Community Health, Family Medicine and Community Health, Prevention Research, Family Medicine and Community Health 2014 - 2021
- Associate Professor in Community and Family Medicine, Family Medicine and Community Health, Prevention Research, Family Medicine and Community Health 2008 - 2014
- Associate Professor in Community and Family Medicine, Family Medicine and Community Health, Prevention Research, Family Medicine and Community Health 2004 - 2008
- Assistant Professor in Community and Family Medicine, Family Medicine and Community Health, Prevention Research, Family Medicine and Community Health 2000 - 2004
- Recognition
-
In the News
-
JUL 9, 2013 News & Observer
-
- Expertise
-
Subject Headings
- 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
- Acetaminophen
- Adaptor Proteins, Signal Transducing
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Mucinous
- Adult
- African Americans
- African Continental Ancestry Group
- Age Distribution
- Age Factors
- Aged
- Aged, 80 and over
- Aging
- Alcohol Drinking
- Alleles
- Amino Acid Substitution
- Analysis of Variance
- Anthropometry
- Anti-Inflammatory Agents, Non-Steroidal
- Apoptosis Regulatory Proteins
- BRCA1 Protein
- BRCA2 Protein
- Base Sequence
- Bayes Theorem
- Biopsy, Needle
- Body Constitution
- Body Mass Index
- Body Size
- Bone Diseases, Metabolic
- Brain Neoplasms
- Breast
- Breast Feeding
- Breast Neoplasms
- Calcium, Dietary
- Carbon-Nitrogen Ligases
- Carcinoma
- Cardiovascular Diseases
- Case-Control Studies
- Caspase 8
- Chemoprevention
- Chemotherapy
- Chi-Square Distribution
- Child
- Chromosomes, Human, Pair 19
- Chromosomes, Human, Pair 5
- Chromosomes, Human, Pair 9
- Cohort Studies
- Colonic Neoplasms
- Colonoscopy
- Colorectal Neoplasms
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Computer Communication Networks
- Confidence Intervals
- Confounding Factors (Epidemiology)
- Contraception
- Contraceptives, Oral
- Contraceptives, Oral, Hormonal
- Cooperative Behavior
- Cross-Sectional Studies
- Curriculum
- Cyclin E
- Cyclin-Dependent Kinase Inhibitor p16
- Cystadenocarcinoma, Serous
- Cytochrome P-450 CYP3A
- DNA
- DNA (Cytosine-5-)-Methyltransferase
- DNA Damage
- DNA Ligases
- DNA Mutational Analysis
- DNA Repair
- DNA-Binding Proteins
- Dairy Products
- Data Collection
- Demography
- Diabetes
- Diabetes Mellitus
- Diet
- Dietary Fats
- Dietary Supplements
- Dihydrouracil Dehydrogenase (NADP)
- Drug Administration Schedule
- Eczema
- Educational Status
- Effect Modifier, Epidemiologic
- Endometrial Neoplasms
- Endometriosis
- Environment
- Environmental Exposure
- Epidemiologic Research Design
- Epidemiologic Studies
- Epithelial Cells
- Estrogen Receptor Modulators
- Estrogen Receptor alpha
- Estrogen Replacement Therapy
- Estrogens
- Europe
- European Continental Ancestry Group
- Exercise
- Exons
- Faculty, Medical
- False Positive Reactions
- Family
- Female
- Female Urogenital Diseases
- Focus Groups
- Folic Acid
- Follicle Stimulating Hormone
- Follow-Up Studies
- Food Contamination
- Gene Expression Profiling
- Gene Frequency
- Gene-Environment Interaction
- Genes, BRCA1
- Genes, p53
- Genetic Heterogeneity
- Genetic Predisposition to Disease
- Genetic Variation
- Genome, Human
- Genome-Wide Association Study
- Genotype
- Georgia
- Glioma
- Glycoproteins
- Guidelines as Topic
- Haplotypes
- Health Behavior
- Health Resources
- Health Services Accessibility
- Health Status
- Heart Diseases
- Heterozygote
- Homozygote
- Hormone Replacement Therapy
- Hormones
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hyperplasia
- Hypersensitivity
- Hypertension
- Hysterectomy
- Immunohistochemistry
- Incidence
- Insulin-Like Growth Factor Binding Protein 1
- Insulin-Like Growth Factor Binding Protein 3
- Insulin-Like Growth Factor Binding Proteins
- Insulin-Like Growth Factor I
- Insulin-Like Growth Factor II
- Interleukin-18
- International Cooperation
- Interviews as Topic
- Isoenzymes
- Kaplan-Meier Estimate
- Keratin-5
- Keratin-6
- Keratins
- Leiomyoma
- Life Style
- Linear Models
- Linkage Disequilibrium
- Logistic Models
- Loss of Heterozygosity
- Lymph Node Excision
- Lymph Nodes
- Lymphatic Metastasis
- Lymphedema
- Magnetic Resonance Imaging
- Male
- Mammography
- Maternal Age
- Medical History Taking
- Medical Records
- Menarche
- Menopause
- Menstrual Cycle
- Menstruation Disturbances
- Methylenetetrahydrofolate Dehydrogenase (NADP)
- Middle Aged
- Minority Groups
- Models, Statistical
- Molecular Epidemiology
- Molecular Sequence Data
- Multivariate Analysis
- Mutation
- National Health Programs
- Needs Assessment
- Neoplasm Grading
- Neoplasm Invasiveness
- Neoplasm Proteins
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Neoplasms
- Neoplasms, Glandular and Epithelial
- Neoplasms, Radiation-Induced
- Nerve Tissue Proteins
- Netherlands
- Neuropeptides
- New Jersey
- North Carolina
- Nuclear Proteins
- Obesity
- Odds Ratio
- Oligonucleotide Array Sequence Analysis
- Ovarian Neoplasms
- Ovary
- Ovulation
- Oxidative Stress
- Pain
- Parity
- Patient Acceptance of Health Care
- Patient Education as Topic
- Patient Participation
- Patient Selection
- Pedigree
- Peptides
- Peritoneal Neoplasms
- Pesticides
- Phenotype
- Physical Fitness
- Polymerase Chain Reaction
- Polymorphism, Genetic
- Polymorphism, Single Nucleotide
- Polymorphism, Single-Stranded Conformational
- Population Surveillance
- Postmenopause
- Postoperative Complications
- Pregnancy
- Premenopause
- Prevalence
- Primary Ovarian Insufficiency
- Probability
- Progestins
- Prognosis
- Promoter Regions, Genetic
- Proportional Hazards Models
- Prospective Studies
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Protein-Serine-Threonine Kinases
- Quality of Life
- Questionnaires
- Race
- Radiation, Ionizing
- Radiotherapy
- Randomized Controlled Trials as Topic
- Receptor, Epidermal Growth Factor
- Receptor, erbB-2
- Receptors, Androgen
- Receptors, Estrogen
- Receptors, Progesterone
- Recreation
- Registries
- Regression Analysis
- Reproducibility of Results
- Reproductive History
- Research
- Residence Characteristics
- Retinoblastoma Protein
- Retrospective Studies
- Risk
- Risk Assessment
- Risk Factors
- Risk Management
- Risk Reduction Behavior
- Severity of Illness Index
- Social Class
- Societies, Medical
- Socioeconomic Factors
- Statistics as Topic
- Survival Analysis
- Survival Rate
- Survivors
- Telomerase
- Thymidylate Synthase
- Time Factors
- Transforming Growth Factor beta1
- Treatment Outcome
- Trinucleotide Repeats
- Tumor Cells, Cultured
- Tumor Markers, Biological
- Tumor Suppressor Protein p53
- United States
- Uterine Cervical Neoplasms
- Uterine Neoplasms
- Veterans
- Vitamin D
- Weight Gain
- Women's Health
- Young Adult
- Research
-
Selected Grants
- Building Interdisciplinary Research Careers in Women's Health awarded by National Institutes of Health 2002 - 2027
- Exploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortium awarded by Emory University 2020 - 2021
- Exploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortium awarded by University of Virginia - Charlottesville 2017 - 2019
- The Epidemiology of Ovarian Cancer in African American Women awarded by University of Virginia - Charlottesville 2015 - 2017
- Anti-Mullerian Hormone Analyses in PROOF Study Participants awarded by Mayo Clinic 2012 - 2017
- Rare Cancer Genetics Registry awarded by Massachusetts General Hospital 2014 - 2016
- Integrating Population and Basic Science in Cancer Research awarded by National Institutes of Health 2009 - 2015
- Epidemiology of Ovarian Cancer in African-American Women awarded by National Institutes of Health 2010 - 2015
- Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer awarded by Agency for Healthcare Research and Quality 2010 - 2012
- The Molecular Epidemiology Of Ovarian Cancer awarded by National Institutes of Health 1998 - 2012
- Ovarian Failure Among Hysterectomized Women awarded by National Institutes of Health 2003 - 2010
- Carolina and Georgia Genetics Network Center awarded by National Institutes of Health 1998 - 2008
- Partnerships to Eliminate Disparities in Cancer Outcomes awarded by National Institutes of Health 2002 - 2007
- Carolina and Georgia Genetics Network Center awarded by National Institutes of Health 1998 - 2004
- Medication Use & Breast Cancer in a Biracial Population awarded by National Institutes of Health 2000 - 2002
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Schildkraut, Joellen M., Courtney Johnson, Lauren F. Dempsey, Bo Qin, Paul Terry, Maxwell Akonde, Edward S. Peters, et al. “Survival of epithelial ovarian cancer in Black women: a society to cell approach in the African American cancer epidemiology study (AACES).” Cancer Causes Control, December 15, 2022, 1–15. https://doi.org/10.1007/s10552-022-01660-0.Full Text Link to Item
-
Ochs-Balcom, Heather M., Courtney Johnson, Kristin A. Guertin, Bo Qin, Alicia Beeghly-Fadiel, Fabian Camacho, Traci N. Bethea, et al. “Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium.” Br J Cancer 127, no. 11 (November 2022): 1983–90. https://doi.org/10.1038/s41416-022-01981-6.Full Text Link to Item
-
Nash, Rebecca, Courtney E. Johnson, Holly R. Harris, Lauren C. Peres, Charlotte E. Joslin, Traci N. Bethea, Elisa V. Bandera, et al. “Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer.” Cancer Epidemiol Biomarkers Prev 31, no. 8 (August 2, 2022): 1610–20. https://doi.org/10.1158/1055-9965.EPI-22-0115.Full Text Link to Item
-
Peres, Lauren C., Christelle Colin-Leitzinger, Sweta Sinha, Jeffrey R. Marks, Jose R. Conejo-Garcia, Anthony J. Alberg, Elisa V. Bandera, et al. “Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.” Cancer Epidemiol Biomarkers Prev 31, no. 5 (May 4, 2022): 1006–16. https://doi.org/10.1158/1055-9965.EPI-21-1334.Full Text Link to Item
-
McBride, Colleen M., Sarita Pathak, Courtney E. Johnson, Anthony J. Alberg, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa L. Bondy, et al. “Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.” Cancer 128, no. 6 (March 15, 2022): 1252–59. https://doi.org/10.1002/cncr.34053.Full Text Link to Item
-
Davis, Colette P., Elisa V. Bandera, Traci N. Bethea, Fabian Camacho, Charlotte E. Joslin, Anna H. Wu, Alicia Beeghly-Fadiel, et al. “Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.” Cancer Epidemiol Biomarkers Prev 30, no. 9 (September 2021): 1660–68. https://doi.org/10.1158/1055-9965.EPI-21-0162.Full Text Link to Item
-
Bethea, Traci N., Heather M. Ochs-Balcom, Elisa V. Bandera, Alicia Beeghly-Fadiel, Fabian Camacho, Deanna Chyn, Emily K. Cloyd, et al. “First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.” Int J Cancer 148, no. 12 (June 15, 2021): 2964–73. https://doi.org/10.1002/ijc.33493.Full Text Link to Item
-
Peres, Lauren C., Traci N. Bethea, Tareq F. Camacho, Elisa V. Bandera, Alicia Beeghly-Fadiel, Deanna L. Chyn, Holly R. Harris, et al. “Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium.” J Natl Cancer Inst 113, no. 6 (June 1, 2021): 710–18. https://doi.org/10.1093/jnci/djaa188.Full Text Link to Item
-
Freedland, Alexis R., Roberto L. Muller, Cathrine Hoyo, Elizabeth L. Turner, Patricia G. Moorman, Eliney F. Faria, Gustavo F. Carvalhal, et al. “Implications of Regionalizing Care in the Developing World: Impact of Distance to Referral Center on Compliance to Biopsy Recommendations in a Brazilian Prostate Cancer Screening Cohort.” Prostate Cancer 2021 (2021): 6614838. https://doi.org/10.1155/2021/6614838.Full Text Link to Item
-
Wang, Tengteng, Patrick T. Bradshaw, Patricia G. Moorman, Sarah J. Nyante, Hazel B. Nichols, Sumitra Shantakumar, Humberto Parada, et al. “Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.” Int J Cancer 147, no. 12 (December 15, 2020): 3404–15. https://doi.org/10.1002/ijc.33174.Full Text Link to Item
-
Zhao, Lingling, Hongliang Liu, Sheng Luo, Patricia G. Moorman, Kyle M. Walsh, Wei Li, and Qingyi Wei. “Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk.” Cancer Med 9, no. 24 (December 2020): 9620–31. https://doi.org/10.1002/cam4.3603.Full Text Open Access Copy Link to Item
-
Staples, Jeanine N., Lauren C. Peres, Fabian Camacho, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa L. Bondy, et al. “Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).” Gynecol Oncol 158, no. 1 (July 2020): 123–29. https://doi.org/10.1016/j.ygyno.2020.04.700.Full Text Link to Item
-
Manichaikul, Ani, Lauren C. Peres, Xin-Qun Wang, Mollie E. Barnard, Deanna Chyn, Xin Sheng, Zhaohui Du, et al. “Identification of novel epithelial ovarian cancer loci in women of African ancestry.” Int J Cancer 146, no. 11 (June 1, 2020): 2987–98. https://doi.org/10.1002/ijc.32653.Full Text Link to Item
-
Qian, Danwen, Hongliang Liu, Lingling Zhao, Xiaomeng Wang, Sheng Luo, Patricia G. Moorman, Edward F. Patz, et al. “Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival.” Transl Lung Cancer Res 9, no. 3 (June 2020): 575–86. https://doi.org/10.21037/tlcr-19-318.Full Text Open Access Copy Link to Item
-
Wang, Tengteng, Hazel B. Nichols, Sarah J. Nyante, Patrick T. Bradshaw, Patricia G. Moorman, Geoffrey C. Kabat, Humberto Parada, et al. “Urinary Estrogen Metabolites and Long-Term Mortality Following Breast Cancer.” Jnci Cancer Spectr 4, no. 3 (June 2020): pkaa014. https://doi.org/10.1093/jncics/pkaa014.Full Text Link to Item
-
Tang, Dongfang, Yu Chen Zhao, Danwen Qian, Hongliang Liu, Sheng Luo, Edward F. Patz, Patricia G. Moorman, et al. “Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.” Mol Carcinog 59, no. 1 (January 2020): 104–15. https://doi.org/10.1002/mc.23132.Full Text Open Access Copy Link to Item
-
Mullins, Megan A., Lauren C. Peres, Anthony J. Alberg, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa L. Bondy, Ellen Funkhouser, et al. “Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.” Cancer 125, no. 24 (December 15, 2019): 4442–51. https://doi.org/10.1002/cncr.32451.Full Text Link to Item
-
Ge, Jie, Hongliang Liu, Danwen Qian, Xiaomeng Wang, Patricia G. Moorman, Sheng Luo, Shelley Hwang, and Qingyi Wei. “Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study.” Int J Cancer 145, no. 5 (September 1, 2019): 1270–79. https://doi.org/10.1002/ijc.32371.Full Text Open Access Copy Link to Item
-
Peres, Lauren C., James R. Hebert, Bo Qin, Kristin A. Guertin, Elisa V. Bandera, Nitin Shivappa, Tareq F. Camacho, et al. “Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma.” J Nutr 149, no. 9 (September 1, 2019): 1606–16. https://doi.org/10.1093/jn/nxz098.Full Text Link to Item
-
Schildkraut, Joellen M., Lauren C. Peres, Traci N. Bethea, Fabian Camacho, Deanna Chyn, Emily K. Cloyd, Elisa V. Bandera, et al. “Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.” Cancer Causes Control 30, no. 9 (September 2019): 967–78. https://doi.org/10.1007/s10552-019-01199-7.Full Text Link to Item
-
Chen, Ka, Hongliang Liu, Zhensheng Liu, Sheng Luo, Edward F. Patz, Patricia G. Moorman, Li Su, Sipeng Shen, David C. Christiani, and Qingyi Wei. “Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.” Int J Cancer 145, no. 3 (August 1, 2019): 621–31. https://doi.org/10.1002/ijc.32128.Full Text Open Access Copy Link to Item
-
Guo, Yi, Yun Feng, Hongliang Liu, Sheng Luo, Jeffrey W. Clarke, Patricia G. Moorman, Li Su, Sipeng Shen, David C. Christiani, and Qingyi Wei. “Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.” Mol Carcinog 58, no. 7 (July 2019): 1094–1104. https://doi.org/10.1002/mc.23017.Full Text Open Access Copy Link to Item
-
Grant, Delores J., Ani Manichaikul, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.” Cancer Med 8, no. 5 (May 2019): 2503–13. https://doi.org/10.1002/cam4.1996.Full Text Link to Item
-
Qian, Danwen, Hongliang Liu, Xiaomeng Wang, Jie Ge, Sheng Luo, Edward F. Patz, Patricia G. Moorman, et al. “Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.” Int J Cancer 144, no. 8 (April 15, 2019): 1867–76. https://doi.org/10.1002/ijc.31896.Full Text Open Access Copy Link to Item
-
Moorman, Patricia G., Nadine J. Barrett, Frances Wang, J Anthony Alberg, Elisa V. Bandera, J. B. Barnholtz-Sloan, Melissa Bondy, et al. “Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women.” J Womens Health (Larchmt) 28, no. 4 (April 2019): 444–51. https://doi.org/10.1089/jwh.2018.7031.Full Text Link to Item
-
Mills, Anne M., Lauren C. Peres, Alice Meiss, Kari L. Ring, Susan C. Modesitt, Sarah E. Abbott, Anthony J. Alberg, et al. “Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).” Int J Gynecol Pathol 38, no. 2 (March 2019): 157–70. https://doi.org/10.1097/PGP.0000000000000494.Full Text Link to Item
-
Anderson, Roger T., Lauren C. Peres, Fabian Camacho, Elisa V. Bandera, Ellen Funkhouser, Patricia G. Moorman, Lisa E. Paddock, et al. “Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study.” J Womens Health (Larchmt) 28, no. 2 (February 2019): 284–93. https://doi.org/10.1089/jwh.2018.7025.Full Text Link to Item
-
Yang, Yaohua, Lang Wu, Xiang Shu, Yingchang Lu, Xiao-Ou Shu, Qiuyin Cai, Alicia Beeghly-Fadiel, et al. “Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.” Cancer Res 79, no. 3 (February 1, 2019): 505–17. https://doi.org/10.1158/0008-5472.CAN-18-2726.Full Text Link to Item
-
Park, Hyo K., Joellen M. Schildkraut, Anthony J. Alberg, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa Bondy, Sydnee Crankshaw, et al. “Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.” Cancer Causes Control 29, no. 11 (November 2018): 1081–91. https://doi.org/10.1007/s10552-018-1082-4.Full Text Link to Item
-
Freedman, Jennifer A., Yanru Wang, Xuechan Li, Hongliang Liu, Patricia G. Moorman, Daniel J. George, Norman H. Lee, Terry Hyslop, Qingyi Wei, and Steven R. Patierno. “Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.” Carcinogenesis 39, no. 7 (July 3, 2018): 879–88. https://doi.org/10.1093/carcin/bgy062.Full Text Open Access Copy Link to Item
-
Peres, Lauren C., Harvey Risch, Kathryn L. Terry, Penelope M. Webb, Marc T. Goodman, Anna H. Wu, Anthony J. Alberg, et al. “Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.” Int J Epidemiol 47, no. 3 (June 1, 2018): 1011. https://doi.org/10.1093/ije/dyy054.Full Text Link to Item
-
Peres, Lauren C., Harvey Risch, Kathryn L. Terry, Penelope M. Webb, Marc T. Goodman, Anna H. Wu, Anthony J. Alberg, et al. “Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.” Int J Epidemiol 47, no. 2 (April 1, 2018): 460–72. https://doi.org/10.1093/ije/dyx252.Full Text Link to Item
-
DeBono, Nathan L., Whitney R. Robinson, Jennifer L. Lund, Chiu Kit Tse, Patricia G. Moorman, Andrew F. Olshan, and Melissa A. Troester. “Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.” J Womens Health (Larchmt) 27, no. 3 (March 2018): 377–86. https://doi.org/10.1089/jwh.2016.6063.Full Text Link to Item
-
Abbott, Sarah E., Fabian Camacho, Lauren C. Peres, Anthony J. Alberg, Elisa V. Bandera, Melissa Bondy, Michele L. Cote, et al. “Recreational physical activity and survival in African-American women with ovarian cancer.” Cancer Causes Control 29, no. 1 (January 2018): 77–86. https://doi.org/10.1007/s10552-017-0986-8.Full Text Link to Item
-
McNamara, Chrissy, Sarah E. Abbott, Elisa V. Bandera, Bo Qin, Lauren C. Peres, Fabian Camacho, Patricia G. Moorman, et al. “Tubal ligation and ovarian cancer risk in African American women.” Cancer Causes Control 28, no. 10 (October 2017): 1033–41. https://doi.org/10.1007/s10552-017-0943-6.Full Text Link to Item
-
Wang, Yanru, Jennifer A. Freedman, Hongliang Liu, Patricia G. Moorman, Terry Hyslop, Daniel J. George, Norman H. Lee, Steven R. Patierno, and Qingyi Wei. “Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.” Int J Cancer 141, no. 4 (August 15, 2017): 731–43. https://doi.org/10.1002/ijc.30787.Full Text Link to Item
-
Kelemen, Linda E., Sarah Abbott, Bo Qin, Lauren Cole Peres, Patricia G. Moorman, Kristin Wallace, Elisa V. Bandera, et al. “Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).” Cancer Causes Control 28, no. 7 (July 2017): 699–708. https://doi.org/10.1007/s10552-017-0899-6.Full Text Link to Item
-
Peres, Lauren C., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.” Am J Epidemiol 186, no. 1 (July 1, 2017): 46–53. https://doi.org/10.1093/aje/kwx055.Full Text Link to Item
-
Qin, Bo, Patricia G. Moorman, Linda E. Kelemen, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Dietary Quality and Ovarian Cancer Risk in African-American Women.” Am J Epidemiol 185, no. 12 (June 15, 2017): 1281–89. https://doi.org/10.1093/aje/kwx022.Full Text Link to Item
-
Peres, Lauren C., Patricia G. Moorman, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.” Cancer Causes Control 28, no. 5 (May 2017): 405–14. https://doi.org/10.1007/s10552-017-0853-7.Full Text Link to Item
-
Terry, Paul D., Bo Qin, Fabian Camacho, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, et al. “Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women.” J Nutr 147, no. 4 (April 2017): 621–27. https://doi.org/10.3945/jn.116.243279.Full Text Link to Item
-
Horick, Nora K., Adoma Manful, Jan Lowery, Susan Domchek, Patricia Moorman, Constance Griffin, Kala Visvanathan, Claudine Isaacs, Anita Y. Kinney, and Dianne M. Finkelstein. “Physical and psychological health in rare cancer survivors.” J Cancer Surviv 11, no. 1 (February 2017): 158–65. https://doi.org/10.1007/s11764-016-0573-0.Full Text Link to Item
-
Peres, Lauren C., Elisa V. Bandera, Bo Qin, Kristin A. Guertin, Nitin Shivappa, James R. Hebert, Sarah E. Abbott, et al. “Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.” Int J Cancer 140, no. 3 (February 1, 2017): 535–43. https://doi.org/10.1002/ijc.30467.Full Text Link to Item
-
Barrett, Nadine J., Kearston L. Ingraham, Tracey Vann Hawkins, and Patricia G. Moorman. “Engaging African Americans in Research: The Recruiter's Perspective.” Ethn Dis 27, no. 4 (2017): 453–62. https://doi.org/10.18865/ed.27.4.453.Full Text Open Access Copy Link to Item
-
Qin, Bo, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Dairy, calcium, vitamin D and ovarian cancer risk in African-American women.” Br J Cancer 115, no. 9 (October 25, 2016): 1122–30. https://doi.org/10.1038/bjc.2016.289.Full Text Link to Item
-
Schildkraut, Joellen M., Sarah E. Abbott, Anthony J. Alberg, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa L. Bondy, Michele L. Cote, et al. “Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).” Cancer Epidemiol Biomarkers Prev 25, no. 10 (October 2016): 1411–17. https://doi.org/10.1158/1055-9965.EPI-15-1281.Full Text Link to Item
-
Trabuco, Emanuel C., Patricia G. Moorman, and William A. Cliby. “In Reply.” Obstet Gynecol 128, no. 3 (September 2016): 655–56. https://doi.org/10.1097/AOG.0000000000001607.Full Text Link to Item
-
Moorman, Patricia G., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Reproductive factors and ovarian cancer risk in African-American women.” Ann Epidemiol 26, no. 9 (September 2016): 654–62. https://doi.org/10.1016/j.annepidem.2016.07.004.Full Text Link to Item
-
Alberg, Anthony J., Patricia G. Moorman, Sydnee Crankshaw, Frances Wang, Elisa V. Bandera, Jill S. Barnholtz-Sloan, Melissa Bondy, et al. “Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study.” Am J Epidemiol 184, no. 4 (August 15, 2016): 274–83. https://doi.org/10.1093/aje/kwv450.Full Text Link to Item
-
Bandera, Elisa V., Bo Qin, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Obesity, weight gain, and ovarian cancer risk in African American women.” Int J Cancer 139, no. 3 (August 1, 2016): 593–600. https://doi.org/10.1002/ijc.30115.Full Text Link to Item
-
Abbott, Sarah E., Elisa V. Bandera, Bo Qin, Lauren C. Peres, Patricia G. Moorman, Jill Barnholtz-Sloan, Ann G. Schwartz, et al. “Recreational physical activity and ovarian cancer risk in African American women.” Cancer Med 5, no. 6 (June 2016): 1319–27. https://doi.org/10.1002/cam4.677.Full Text Link to Item
-
Erondu, Chioma O., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer.” J Womens Health (Larchmt) 25, no. 6 (June 2016): 571–78. https://doi.org/10.1089/jwh.2015.5359.Full Text Link to Item
-
Trabuco, Emanuel C., Patricia G. Moorman, Alicia Algeciras-Schimnich, Amy L. Weaver, and William A. Cliby. “Association of Ovary-Sparing Hysterectomy With Ovarian Reserve.” Obstet Gynecol 127, no. 5 (May 2016): 819–27. https://doi.org/10.1097/AOG.0000000000001398.Full Text Link to Item
-
Myers, Evan R., Patricia Moorman, and Gillian D. Sanders. “Breast Cancer Screening: Benefit or Harm?--Reply.” Jama 315, no. 13 (April 5, 2016): 1402–3. https://doi.org/10.1001/jama.2015.19129.Full Text Link to Item
-
Peres, Lauren C., Fabian Camacho, Sarah E. Abbott, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, et al. “Analgesic medication use and risk of epithelial ovarian cancer in African American women.” Br J Cancer 114, no. 7 (March 29, 2016): 819–25. https://doi.org/10.1038/bjc.2016.39.Full Text Link to Item
-
Qin, Bo, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women.” Br J Nutr 115, no. 4 (February 28, 2016): 694–702. https://doi.org/10.1017/S0007114515004882.Full Text Link to Item
-
Bolton, K. L., J. Tyrer, H. Song, S. J. Ramus, M. Notaridou, C. Jones, T. Sher, et al. “Erratum: Common variants at 19p13 are associated with susceptibility to ovarian cancer (Nature Genetics (2010) 42 (880-884)).” Nature Genetics 48, no. 1 (December 29, 2015): 101. https://doi.org/10.1038/ng0116-101b.Full Text
-
Moorman, Patricia G. “Should women at high risk for cancer use oral contraceptive pills?” Per Med 12, no. 6 (November 2015): 533–35. https://doi.org/10.2217/pme.15.36.Full Text Link to Item
-
Myers, Evan R., Patricia Moorman, Jennifer M. Gierisch, Laura J. Havrilesky, Lars J. Grimm, Sujata Ghate, Brittany Davidson, et al. “Benefits and Harms of Breast Cancer Screening: A Systematic Review.” Jama 314, no. 15 (October 20, 2015): 1615–34. https://doi.org/10.1001/jama.2015.13183.Full Text Link to Item
-
Davidson, Brittany Anne, and Patricia G. Moorman. “Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.” Expert Opin Drug Saf 13, no. 10 (October 2014): 1375–82. https://doi.org/10.1517/14740338.2014.951327.Full Text Link to Item
-
Schildkraut, Joellen M., Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michelle L. Cote, Ellen Funkhouser, et al. “A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES).” Bmc Cancer 14 (September 22, 2014): 688. https://doi.org/10.1186/1471-2407-14-688.Full Text Link to Item
-
Allott, E. H., C. -. K. Tse, A. F. Olshan, L. A. Carey, P. G. Moorman, and M. A. Troester. “Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.” Breast Cancer Res Treat 147, no. 2 (September 2014): 415–21. https://doi.org/10.1007/s10549-014-3099-z.Full Text Link to Item
-
Hill, Deirdre A., Nora K. Horick, Claudine Isaacs, Susan M. Domchek, Gail E. Tomlinson, Jan T. Lowery, Anita Y. Kinney, et al. “Long-term risk of medical conditions associated with breast cancer treatment.” Breast Cancer Res Treat 145, no. 1 (May 2014): 233–43. https://doi.org/10.1007/s10549-014-2928-4.Full Text Link to Item
-
Wordlaw-Stinson, LaShawn, Sierra Jones, Shaneese Little, Laura Fish, Adriana Vidal, Jennifer S. Smith, Cathrine Hoyo, and Patricia G. Moorman. “Challenges and Recommendations to Recruiting Women Who Do Not Adhere to Follow-Up Gynecological Care.” Open J Prev Med 4, no. 3 (March 20, 2014): 123–28. https://doi.org/10.4236/ojpm.2014.43017.Full Text Link to Item
-
Trabuco, Emanuel C., Patricia G. Moorman, Amy L. Weaver, and Cliby A. William. “Anti-Mullerian Hormone and Ovarian Function after Hysterectomy.” Reproductive Sciences 21, no. 3 (March 1, 2014): 101A-102A.Link to Item
-
Allott, E. H., M. R. Abern, L. Gerber, C. J. Keto, W. J. Aronson, M. K. Terris, C. J. Kane, et al. “Metformin does not affect risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database.” Prostate Cancer and Prostatic Diseases 16, no. 4 (December 1, 2013): 391–97. https://doi.org/10.1038/pcan.2013.48.Full Text
-
Allott, E. H., M. R. Abern, L. Gerber, C. J. Keto, W. J. Aronson, M. K. Terris, C. J. Kane, et al. “Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.” Prostate Cancer Prostatic Dis 16, no. 4 (December 2013): 391–97. https://doi.org/10.1038/pcan.2013.48.Full Text Link to Item
-
Moorman, Patricia G., Laura J. Havrilesky, Jennifer M. Gierisch, Remy R. Coeytaux, William J. Lowery, Rachel Peragallo Urrutia, Michaela Dinan, et al. “Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.” J Clin Oncol 31, no. 33 (November 20, 2013): 4188–98. https://doi.org/10.1200/JCO.2013.48.9021.Full Text Link to Item
-
Gierisch, Jennifer M., Remy R. Coeytaux, Rachel Peragallo Urrutia, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, Michaela Dinan, et al. “Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.” Cancer Epidemiol Biomarkers Prev 22, no. 11 (November 2013): 1931–43. https://doi.org/10.1158/1055-9965.EPI-13-0298.Full Text Link to Item
-
Peragallo Urrutia, Rachel, Remy R. Coeytaux, Amanda J. McBroom, Jennifer M. Gierisch, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, et al. “Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.” Obstet Gynecol 122, no. 2 Pt 1 (August 2013): 380–89. https://doi.org/10.1097/AOG.0b013e3182994c43.Full Text Link to Item
-
Havrilesky, Laura J., Patricia G. Moorman, William J. Lowery, Jennifer M. Gierisch, Remy R. Coeytaux, Rachel Peragallo Urrutia, Michaela Dinan, et al. “Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.” Obstet Gynecol 122, no. 1 (July 2013): 139–47. https://doi.org/10.1097/AOG.0b013e318291c235.Full Text Link to Item
-
Havrilesky, Laura J., Jennifer M. Gierisch, Patricia G. Moorman, Remy R. Coeytaux, Rachel Peragallo Urrutia, William J. Lowery, Michaela Dinan, et al. “Oral contraceptive use for the primary prevention of ovarian cancer.” Evid Rep Technol Assess (Full Rep), no. 212 (June 2013): 1–514.Link to Item
-
Pearce, Celeste Leigh, Mary Anne Rossing, Alice W. Lee, Roberta B. Ness, Penelope M. Webb, Penelope M. for Australian Cancer Study (Ovarian Cancer), Penelope M. Australian Ovarian Cancer Study Group, et al. “Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.” Cancer Epidemiol Biomarkers Prev 22, no. 5 (May 2013): 880–90. https://doi.org/10.1158/1055-9965.EPI-12-1030-T.Full Text Link to Item
-
Olsen, Catherine M., Christina M. Nagle, David C. Whiteman, Roberta Ness, Celeste Leigh Pearce, Malcolm C. Pike, Mary Anne Rossing, et al. “Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.” Endocr Relat Cancer 20, no. 2 (April 2013): 251–62. https://doi.org/10.1530/ERC-12-0395.Full Text Link to Item
-
Moorman, Patricia G., Phyllis Leppert, Evan R. Myers, and Frances Wang. “Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.” Fertil Steril 99, no. 3 (March 1, 2013): 768-776.e1. https://doi.org/10.1016/j.fertnstert.2012.10.039.Full Text Link to Item
-
Fish, Laura J., Patricia G. Moorman, Lashawn Wordlaw-Stintson, Adriana Vidal, Jennifer S. Smith, and Cathrine Hoyo. “Factors Associated With Adherence to Follow-up Colposcopy.” Am J Health Educ 44, no. 6 (2013): 293–98. https://doi.org/10.1080/19325037.2013.838881.Full Text Link to Item
-
Peragallo Urrutia, R., R. R. Coeytaux, A. J. McBroom, J. M. Gierisch, L. J. Havrilesky, P. G. Moorman, W. J. Lowery, et al. “Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.” Obstetrics and Gynecology 122, no. 2 Pt 1 (January 1, 2013): 380–89.
-
Moorman, Patricia G. “Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?” Per Med 9, no. 6 (August 2012): 565–67. https://doi.org/10.2217/pme.12.58.Full Text Link to Item
-
Moorman, Patricia G., Evan R. Myers, Joellen M. Schildkraut, Edwin S. Iversen, Frances Wang, and Nicolette Warren. “Effect of hysterectomy with ovarian preservation on ovarian function.” Obstet Gynecol 118, no. 6 (December 2011): 1271–79. https://doi.org/10.1097/AOG.0b013e318236fd12.Full Text Link to Item
-
Moorman, Patricia G. “Reply: "age at menopause: imputing age at menopause for women with a hysterectomy with application to risk of postmenopausal breast cancer".” Ann Epidemiol 21, no. 10 (October 2011): 797. https://doi.org/10.1016/j.annepidem.2011.04.009.Full Text Link to Item
-
Ziogas, Argyrios, Nora K. Horick, Anita Y. Kinney, Jan T. Lowery, Susan M. Domchek, Claudine Isaacs, Constance A. Griffin, et al. “Clinically relevant changes in family history of cancer over time.” Jama 306, no. 2 (July 13, 2011): 172–78. https://doi.org/10.1001/jama.2011.955.Full Text Link to Item
-
Moorman, Patricia G., Joellen M. Schildkraut, Evan R. Myers, and Frances Wang. “Reported symptoms before and one year after hysterectomy in African American and white women.” J Womens Health (Larchmt) 20, no. 7 (July 2011): 1035–42. https://doi.org/10.1089/jwh.2010.2543.Full Text Link to Item
-
Pearce, Celeste Leigh, Jennifer A. Doherty, David J. Van Den Berg, Kirsten Moysich, Chris Hsu, Kara L. Cushing-Haugen, David V. Conti, et al. “Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.” Hum Mol Genet 20, no. 11 (June 1, 2011): 2263–72. https://doi.org/10.1093/hmg/ddr087.Full Text Link to Item
-
Notaridou, Maria, Lydia Quaye, Dimitra Dafou, Chris Jones, Honglin Song, Estrid Høgdall, Susanne K. Kjaer, et al. “Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.” Int J Cancer 128, no. 9 (May 1, 2011): 2063–74. https://doi.org/10.1002/ijc.25554.Full Text Link to Item
-
Moorman, Patricia G., Lee W. Jones, Lucy Akushevich, and Joellen M. Schildkraut. “Recreational physical activity and ovarian cancer risk and survival.” Ann Epidemiol 21, no. 3 (March 2011): 178–87. https://doi.org/10.1016/j.annepidem.2010.10.014.Full Text Link to Item
-
Near, Aimee M., Anna H. Wu, Claire Templeman, David J. Van Den Berg, Jennifer A. Doherty, Mary Anne Rossing, Ellen L. Goode, et al. “Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.” Fertil Steril 95, no. 1 (January 2011): 40–45. https://doi.org/10.1016/j.fertnstert.2010.06.059.Full Text Link to Item
-
Moorman, Patricia G., Edwin S. Iversen, P Kelly Marcom, Jeffrey R. Marks, Frances Wang, Frances Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Eunjung Lee, et al. “Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.” Breast Cancer Res Treat 124, no. 2 (November 2010): 441–51. https://doi.org/10.1007/s10549-010-0842-y.Full Text Link to Item
-
Bolton, Kelly L., Jonathan Tyrer, Honglin Song, Susan J. Ramus, Maria Notaridou, Chris Jones, Tanya Sher, et al. “Common variants at 19p13 are associated with susceptibility to ovarian cancer.” Nat Genet 42, no. 10 (October 2010): 880–84. https://doi.org/10.1038/ng.666.Full Text Link to Item
-
Johnatty, Sharon E., Jonathan Beesley, Xiaoqing Chen, Stuart Macgregor, David L. Duffy, Amanda B. Spurdle, Anna deFazio, et al. “Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".” Plos Genet 6, no. 7 (July 8, 2010): e1001016. https://doi.org/10.1371/journal.pgen.1001016.Full Text Link to Item
-
Johnatty, S. E., J. Beesley, X. Chen, S. Macgregor, D. L. Duffy, A. B. Spurdle, A. deFazio, et al. “Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".” Plos Genetics 6, no. 7 (July 1, 2010).
-
Grant, Delores J., Patricia G. Moorman, Lucy Akushevich, Rachel T. Palmieri, Rex C. Bentley, and Joellen M. Schildkraut. “Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.” Cancer Causes Control 21, no. 7 (July 2010): 991–98. https://doi.org/10.1007/s10552-010-9525-6.Full Text Link to Item
-
Kelemen, Linda E., Marc T. Goodman, Valerie McGuire, Mary Anne Rossing, Penelope M. Webb, Penelope M. Australian Cancer Study (Ovarian Cancer) Study Group, Martin Köbel, et al. “Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.” Cancer Epidemiol Biomarkers Prev 19, no. 7 (July 2010): 1822–30. https://doi.org/10.1158/1055-9965.EPI-09-1317.Full Text Link to Item
-
Schildkraut, Joellen M., Edwin S. Iversen, Melanie A. Wilson, Merlise A. Clyde, Patricia G. Moorman, Rachel T. Palmieri, Regina Whitaker, Rex C. Bentley, Jeffrey R. Marks, and Andrew Berchuck. “Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.” Plos One 5, no. 4 (April 8, 2010): e10061. https://doi.org/10.1371/journal.pone.0010061.Full Text Open Access Copy Link to Item
-
Doherty, Jennifer A., Mary Anne Rossing, Kara L. Cushing-Haugen, Chu Chen, David J. Van Den Berg, Anna H. Wu, Malcolm C. Pike, et al. “ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.” Cancer Epidemiol Biomarkers Prev 19, no. 1 (January 2010): 245–50. https://doi.org/10.1158/1055-9965.EPI-09-0729.Full Text Link to Item
-
Witt, Kristine L., Patricia G. Moorman, Olga Kovalchuk, Nina Holland, Gladys Block, and Paul R. Andreassen. “Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics.” Environ Mol Mutagen 51, no. 8–9 (2010): 774–80. https://doi.org/10.1002/em.20607.Full Text Link to Item
-
Pearce, C. L., A. M. Near, D. J. Van Den Berg, S. J. Ramus, A. Gentry-Maharaj, U. Menon, S. A. Gayther, et al. “Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com).” British Journal of Cancer 101, no. 10 (November 1, 2009): 1805. https://doi.org/10.1038/sj.bjc.6605431.Full Text
-
Moorman, Patricia G., Rachel T. Palmieri, Lucy Akushevich, Andrew Berchuck, and Joellen M. Schildkraut. “Ovarian cancer risk factors in African-American and white women.” Am J Epidemiol 170, no. 5 (September 1, 2009): 598–606. https://doi.org/10.1093/aje/kwp176.Full Text Link to Item
-
Song, Honglin, Susan J. Ramus, Jonathan Tyrer, Kelly L. Bolton, Aleksandra Gentry-Maharaj, Eva Wozniak, Hoda Anton-Culver, et al. “A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.” Nat Genet 41, no. 9 (September 2009): 996–1000. https://doi.org/10.1038/ng.424.Full Text Link to Item
-
Moorman, P. G. “Challenges of Epidemiologic Research in the Genomic Era: The Example of Ovarian Cancer.” Environmental and Molecular Mutagenesis 50, no. 7 (August 1, 2009): 553–553.Link to Item
-
Song, Honglin, Susan J. Ramus, Susanne Krüger Kjaer, Richard A. DiCioccio, Georgia Chenevix-Trench, Celeste Leigh Pearce, Estrid Hogdall, et al. “Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.” Hum Mol Genet 18, no. 12 (June 15, 2009): 2297–2304. https://doi.org/10.1093/hmg/ddp138.Full Text Link to Item
-
Moorman, Patricia G., Joellen M. Schildkraut, Edwin S. Iversen, Evan R. Myers, Margaret Gradison, Nicolette Warren-White, and Frances Wang. “A prospective study of weight gain after premenopausal hysterectomy.” J Womens Health (Larchmt) 18, no. 5 (May 2009): 699–708. https://doi.org/10.1089/jwh.2008.1019.Full Text Link to Item
-
Il’yasova, Dora, Bridget McCarthy, Jennifer Marcello, Joellen M. Schildkraut, Patricia G. Moorman, Bhuma Krishnamachari, Francis Ali-Osman, Darell D. Bigner, and Faith Davis. “Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.” Cancer Epidemiol Biomarkers Prev 18, no. 4 (April 2009): 1232–38. https://doi.org/10.1158/1055-9965.EPI-08-0995.Full Text Link to Item
-
Schildkraut, Joellen M., Ellen L. Goode, Merlise A. Clyde, Edwin S. Iversen, Patricia G. Moorman, Andrew Berchuck, Jeffrey R. Marks, et al. “Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.” Cancer Res 69, no. 6 (March 15, 2009): 2349–57. https://doi.org/10.1158/0008-5472.CAN-08-2902.Full Text Link to Item
-
Pearce, C. L., A. M. Near, D. J. Van Den Berg, S. J. Ramus, A. Gentry-Maharaj, U. Menon, S. A. Gayther, et al. “Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.” Br J Cancer 100, no. 2 (January 27, 2009): 412–20. https://doi.org/10.1038/sj.bjc.6604820.Full Text Link to Item
-
Pearce, C. L., A. M. Near, D. J. Van Den Berg, S. J. Ramus, A. Gentry-Maharaj, U. Menon, S. A. Gayther, et al. “Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.” British Journal of Cancer 100, no. 2 (January 27, 2009): 412–20. https://doi.org/10.1038/sj.bjc.6604820.Full Text
-
Palmieri, Rachel T., Melanie A. Wilson, Edwin S. Iversen, Merlise A. Clyde, Brian Calingaert, Patricia G. Moorman, Charles Poole, et al. “Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.” Cancer Epidemiol Biomarkers Prev 17, no. 12 (December 2008): 3567–72. https://doi.org/10.1158/1055-9965.EPI-08-0548.Full Text Link to Item
-
Ramus, Susan J., Robert A. Vierkant, Sharon E. Johnatty, Malcolm C. Pike, David J. Van Den Berg, Anna H. Wu, Celeste Leigh Pearce, et al. “Consortium analysis of 7 candidate SNPs for ovarian cancer.” Int J Cancer 123, no. 2 (July 15, 2008): 380–88. https://doi.org/10.1002/ijc.23448.Full Text Link to Item
-
Risch, Harvey A. “Cyclin E overexpression relates to ovarian cancer histology but not to risk factors.” Cancer Epidemiol Biomarkers Prev 17, no. 7 (July 2008): 1841. https://doi.org/10.1158/1055-9965.EPI-08-0271.Full Text Link to Item
-
Millikan, R. C., B. Newman, C. K. Tse, P. G. Moorman, K. Conway, L. G. Dressler, L. V. Smith, et al. “Epidemiology of basal-like breast cancer (Breast Cancer Research and Treatment DOI: 10.1007/s10549-007-9632-6).” Breast Cancer Research and Treatment 109, no. 1 (May 1, 2008): 141. https://doi.org/10.1007/s10549-007-9790-6.Full Text
-
Millikan, Robert C., Beth Newman, Chiu-Kit Tse, Patricia G. Moorman, Kathleen Conway, Lynn G. Dressler, Lisa V. Smith, et al. “Epidemiology of basal-like breast cancer.” Breast Cancer Res Treat 109, no. 1 (May 2008): 123–39. https://doi.org/10.1007/s10549-007-9632-6.Full Text Link to Item
-
Moorman, Patricia G., Brian Calingaert, Rachel T. Palmieri, Edwin S. Iversen, Rex C. Bentley, Susan Halabi, Andrew Berchuck, and Joellen M. Schildkraut. “Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.” Am J Epidemiol 167, no. 9 (May 1, 2008): 1059–69. https://doi.org/10.1093/aje/kwn006.Full Text Link to Item
-
Schildkraut, Joellen M., Patricia G. Moorman, Amy E. Bland, Susan Halabi, Brian Calingaert, Regina Whitaker, Paula S. Lee, et al. “Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.” Cancer Epidemiol Biomarkers Prev 17, no. 3 (March 2008): 585–93. https://doi.org/10.1158/1055-9965.EPI-07-0596.Full Text Link to Item
-
Hulka, Barbara S., and Patricia G. Moorman. “Breast cancer: hormones and other risk factors.” Maturitas 61, no. 1–2 (2008): 203–13. https://doi.org/10.1016/j.maturitas.2008.11.016.Full Text Link to Item
-
Trivers, Katrina F., Marilie D. Gammon, Page E. Abrahamson, Mary Jo Lund, Elaine W. Flagg, Patricia G. Moorman, Jay S. Kaufman, et al. “Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.” Cancer Epidemiol Biomarkers Prev 16, no. 9 (September 2007): 1822–27. https://doi.org/10.1158/1055-9965.EPI-07-0053.Full Text Link to Item
-
Shantakumar, Sumitra, Mary Beth Terry, Andrea Paykin, Susan L. Teitelbaum, Julie A. Britton, Patricia G. Moorman, Stephen B. Kritchevsky, Alfred I. Neugut, and Marilie D. Gammon. “Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.” Am J Epidemiol 165, no. 10 (May 15, 2007): 1187–98. https://doi.org/10.1093/aje/kwm006.Full Text Link to Item
-
Shantakumar, Sumitra, Mary Beth Terry, Susan L. Teitelbaum, Julie A. Britton, Robert C. Millikan, Patricia G. Moorman, Alfred I. Neugut, and Marilie D. Gammon. “Reproductive factors and breast cancer risk among older women.” Breast Cancer Res Treat 102, no. 3 (May 2007): 365–74. https://doi.org/10.1007/s10549-006-9343-4.Full Text Link to Item
-
Trivers, Katrina F., Marilie D. Gammon, Page E. Abrahamson, Mary Jo Lund, Elaine W. Flagg, Jay S. Kaufman, Patricia G. Moorman, et al. “Association between reproductive factors and breast cancer survival in younger women.” Breast Cancer Res Treat 103, no. 1 (May 2007): 93–102. https://doi.org/10.1007/s10549-006-9346-1.Full Text Link to Item
-
Moorman, Patricia G., and Robert J. Hamilton. “Statins and cancer risk: what do we know and where do we go from here?” Epidemiology 18, no. 2 (March 2007): 194–96. https://doi.org/10.1097/01.ede.0000254699.31405.e2.Full Text Link to Item
-
Schildkraut, Joellen M., Susan K. Murphy, Rachel T. Palmieri, Edwin Iversen, Patricia G. Moorman, Zhiqing Huang, Susan Halabi, et al. “Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.” Cancer Epidemiol Biomarkers Prev 16, no. 3 (March 2007): 473–80. https://doi.org/10.1158/1055-9965.EPI-06-0868.Full Text Link to Item
-
Conway, Kathleen, Eloise Parrish, Sharon N. Edmiston, Dawn Tolbert, Chiu-Kit Tse, Patricia Moorman, Beth Newman, and Robert C. Millikan. “Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.” Breast Cancer Res 9, no. 3 (2007): R36. https://doi.org/10.1186/bcr1731.Full Text Link to Item
-
Carey, Lisa A., Charles M. Perou, Chad A. Livasy, Lynn G. Dressler, David Cowan, Kathleen Conway, Gamze Karaca, et al. “Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.” Jama 295, no. 21 (June 7, 2006): 2492–2502. https://doi.org/10.1001/jama.295.21.2492.Full Text Link to Item
-
Sansbury, Leah B., Robert C. Millikan, Jane C. Schroeder, Kari E. North, Patricia G. Moorman, Temitope O. Keku, Allan Rene’ de Cotret, Jon Player, and Robert S. Sandler. “COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States).” Cancer Causes Control 17, no. 3 (April 2006): 257–66. https://doi.org/10.1007/s10552-005-0417-0.Full Text Link to Item
-
Schildkraut, Joellen M., Patricia G. Moorman, Susan Halabi, Brian Calingaert, Jeffrey R. Marks, and Andrew Berchuck. “Analgesic drug use and risk of ovarian cancer.” Epidemiology 17, no. 1 (January 2006): 104–7. https://doi.org/10.1097/01.ede.0000190538.55645.f8.Full Text Link to Item
-
Moorman, Patricia G., John Sesay, Veronica Nwosu, Janet Grubber Kane, Allan René de Cotret, Kendra Worley, and Robert Millikan. “Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.” Cancer Epidemiol Biomarkers Prev 14, no. 12 (December 2005): 3013–14. https://doi.org/10.1158/1055-9965.EPI-05-0291.Full Text Link to Item
-
Hoyo, Cathrine, Andrew Berchuck, Susan Halabi, Rex C. Bentley, Patricia Moorman, Brian Calingaert, and Joellen M. Schildkraut. “Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women.” Cancer Causes Control 16, no. 8 (October 2005): 955–63. https://doi.org/10.1007/s10552-005-3205-y.Full Text Link to Item
-
Sansbury, Leah B., Robert C. Millikan, Jane C. Schroeder, Patricia G. Moorman, Kari E. North, and Robert S. Sandler. “Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites.” Am J Epidemiol 162, no. 6 (September 15, 2005): 548–58. https://doi.org/10.1093/aje/kwi248.Full Text Link to Item
-
Hoyo, Cathrine, Kimberly S. H. Yarnall, Celette Sugg Skinner, Patricia G. Moorman, Denethia Sellers, and LaVerne Reid. “Pain predicts non-adherence to pap smear screening among middle-aged African American women.” Prev Med 41, no. 2 (August 2005): 439–45. https://doi.org/10.1016/j.ypmed.2004.11.021.Full Text Link to Item
-
Moorman, Patricia G., Joellen M. Schildkraut, Brian Calingaert, Susan Halabi, and Andrew Berchuck. “Menopausal hormones and risk of ovarian cancer.” Am J Obstet Gynecol 193, no. 1 (July 2005): 76–82. https://doi.org/10.1016/j.ajog.2004.11.013.Full Text Link to Item
-
Spillman, Monique A., Joellen M. Schildkraut, Susan Halabi, Patricia Moorman, Brian Calingaert, Rex C. Bentley, Jeffrey R. Marks, Susan Murphy, and Andrew Berchuck. “Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.” Gynecol Oncol 97, no. 2 (May 2005): 543–49. https://doi.org/10.1016/j.ygyno.2005.01.025.Full Text Link to Item
-
Moorman, Patricia G., Andrew Berchuck, Brian Calingaert, Susan Halabi, and Joellen M. Schildkraut. “Antidepressant medication use [corrected] and risk of ovarian cancer.” Obstet Gynecol 105, no. 4 (April 2005): 725–30. https://doi.org/10.1097/01.AOG.0000157113.98061.eb.Full Text Link to Item
-
Schildkraut, Joellen M., Wendy Demark-Wahnefried, Robert M. Wenham, Janet Grubber, Amy S. Jeffreys, Steven C. Grambow, Jeffrey R. Marks, et al. “IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.” Cancer Epidemiol Biomarkers Prev 14, no. 2 (February 2005): 403–8. https://doi.org/10.1158/1055-9965.EPI-04-0426.Full Text Link to Item
-
Vanbeek, Marta J., John S. Strauss, and Ingrid Nygaard. “Flushing and papules in a middle-aged woman.” Obstet Gynecol 105, no. 2 (February 2005): 397–401. https://doi.org/10.1097/01.AOG.0000151956.00804.78.Full Text Link to Item
-
Hall, Ingrid J., Patricia G. Moorman, Robert C. Millikan, and Beth Newman. “Comparative analysis of breast cancer risk factors among African-American women and White women.” Am J Epidemiol 161, no. 1 (January 1, 2005): 40–51. https://doi.org/10.1093/aje/kwh331.Full Text Link to Item
-
Moorman, P. G., A. Berchuck, B. Calingaert, S. Halabi, and A. M. Schildkraut. “Antidepressant medication use for and risk of ovarian cancer (vol 105, pg 725, 2005).” Obstetrics and Gynecology 105, no. 6 (2005): 1495–1495.Link to Item
-
Moorman, Patricia G. “Association of aspirin use and hormone receptor status with breast cancer risk.” Jama 292, no. 12 (September 22, 2004): 1426. https://doi.org/10.1001/jama.292.12.1426-a.Full Text Link to Item
-
Woloshin, Steven, and Lisa M. Schwartz. “Association of aspirin use and hormone receptor status with breast cancer risk.” Jama 292, no. 12 (September 22, 2004): 1426–27. https://doi.org/10.1001/jama.292.12.1426-b.Full Text Link to Item
-
Moorman, Patricia G., Celette Sugg Skinner, James P. Evans, Beth Newman, James R. Sorenson, Brian Calingaert, Lisa Susswein, T Sydnee Crankshaw, Cathrine Hoyo, and Joellen M. Schildkraut. “Racial differences in enrolment in a cancer genetics registry.” Cancer Epidemiol Biomarkers Prev 13, no. 8 (August 2004): 1349–54.Link to Item
-
Moorman, Patricia G., and Paul D. Terry. “Consumption of dairy products and the risk of breast cancer: a review of the literature.” Am J Clin Nutr 80, no. 1 (July 2004): 5–14. https://doi.org/10.1093/ajcn/80.1.5.Full Text Link to Item
-
Millikan, Robert C., Jon Player, Allan René de Cotret, Patricia Moorman, Gary Pittman, Vani Vannappagari, Chiu-Kit J. Tse, and Temitope Keku. “Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites.” Breast Cancer Res 6, no. 4 (2004): R264–74. https://doi.org/10.1186/bcr786.Full Text Link to Item
-
Moorman, Patricia G., Janet M. Grubber, Robert C. Millikan, and Beth Newman. “Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast.” Cancer Causes Control 14, no. 10 (December 2003): 915–22. https://doi.org/10.1023/b:caco.0000007973.59863.66.Full Text Link to Item
-
Moorman, Patricia G., Janet M. Grubber, Robert C. Millikan, and Beth Newman. “Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast.” Epidemiology 14, no. 3 (May 2003): 307–14.Link to Item
-
Lancaster, Johnathan M., Robert M. Wenham, Susan Halabi, Brian Calingaert, Jeffrey R. Marks, Patricia G. Moorman, Rex C. Bentley, Andrew Berchuck, and Joellen M. Schildkraut. “No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.” Cancer Epidemiol Biomarkers Prev 12, no. 3 (March 2003): 226–27.Link to Item
-
Moorman, Patricia G., Joellen M. Schildkraut, Brian Calingaert, Susan Halabi, Marilyn F. Vine, and Andrew Berchuck. “Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).” Cancer Causes Control 13, no. 9 (November 2002): 807–11. https://doi.org/10.1023/a:1020678100977.Full Text Link to Item
-
Schildkraut, Joellen M., Brian Calingaert, Polly A. Marchbanks, Patricia G. Moorman, and Gustavo C. Rodriguez. “Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.” J Natl Cancer Inst 94, no. 1 (January 2, 2002): 32–38. https://doi.org/10.1093/jnci/94.1.32.Full Text Link to Item
-
Plummer, Patricia, Susan Jackson, Jamie Konarski, Elizabeth Mahanna, Carolyn Dunmore, Georgette Regan, Dianne Mattingly, et al. “Making epidemiologic studies responsive to the needs of participants and communities: the Carolina Breast Cancer Study experience.” Environ Mol Mutagen 39, no. 2–3 (2002): 96–101. https://doi.org/10.1002/em.10045.Full Text Link to Item
-
Moorman, P. G., R. C. Millikan, and B. Newman. “Oral contraceptives and breast cancer among African-american women and white women.” J Natl Med Assoc 93, no. 9 (September 2001): 329–34.Link to Item
-
Moorman, P. G., A. Hamza, J. R. Marks, and J. A. Olson. “Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma.” Cancer 91, no. 12 (June 15, 2001): 2258–62.Link to Item
-
Moorman, P. G., B. Calingaert, M. Vine, S. Halabi, A. Berchuck, and J. M. Schildkraut. “Comparison of two methods for calculating lifetime ovulatory cycles.” American Journal of Epidemiology 153, no. 11 (June 1, 2001): S138–S138.Link to Item
-
Moorman, P. G., M. F. Ricciuti, R. C. Millikan, and B. Newman. “Vitamin supplement use and breast cancer in a North Carolina population.” Public Health Nutr 4, no. 3 (June 2001): 821–27. https://doi.org/10.1079/phn2001121.Full Text Link to Item
-
Hulka, B. S., and P. G. Moorman. “Breast cancer: hormones and other risk factors.” Maturitas 38, no. 1 (February 28, 2001): 103–13. https://doi.org/10.1016/s0378-5122(00)00196-1.Full Text Link to Item
-
Moorman, P. G., B. A. Jones, R. C. Millikan, I. J. Hall, and B. Newman. “Race, anthropometric factors, and stage at diagnosis of breast cancer.” Am J Epidemiol 153, no. 3 (February 1, 2001): 284–91. https://doi.org/10.1093/aje/153.3.284.Full Text Link to Item
-
Moorman, P. G., H. Kuwabara, R. C. Millikan, and B. Newman. “Menopausal hormones and breast cancer in a biracial population.” Am J Public Health 90, no. 6 (June 2000): 966–71. https://doi.org/10.2105/ajph.90.6.966.Full Text Link to Item
-
Hall, I. J., B. Newman, R. C. Millikan, and P. G. Moorman. “Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study.” Am J Epidemiol 151, no. 8 (April 15, 2000): 754–64. https://doi.org/10.1093/oxfordjournals.aje.a010275.Full Text Link to Item
-
Huang, W. Y., B. Newman, R. C. Millikan, M. J. Schell, B. S. Hulka, and P. G. Moorman. “Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.” Am J Epidemiol 151, no. 7 (April 1, 2000): 703–14. https://doi.org/10.1093/oxfordjournals.aje.a010265.Full Text Link to Item
-
Kinney, A. Y., R. C. Millikan, Y. H. Lin, P. G. Moorman, and B. Newman. “Alcohol consumption and breast cancer among black and white women in North Carolina (United States).” Cancer Causes Control 11, no. 4 (April 2000): 345–57. https://doi.org/10.1023/a:1008973709917.Full Text Link to Item
-
Marcus, P. M., B. Newman, R. C. Millikan, P. G. Moorman, D. D. Baird, and B. Qaqish. “The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States).” Cancer Causes Control 11, no. 3 (March 2000): 271–78. https://doi.org/10.1023/a:1008911902994.Full Text Link to Item
-
Marcus, P. M., D. D. Baird, R. C. Millikan, P. G. Moorman, B. Qaqish, and B. Newman. “Adolescent reproductive events and subsequent breast cancer risk.” Am J Public Health 89, no. 8 (August 1999): 1244–47. https://doi.org/10.2105/ajph.89.8.1244.Full Text Link to Item
-
Marcus, P. M., B. Newman, P. G. Moorman, R. C. Millikan, D. D. Baird, B. Qaqish, and B. Sternfeld. “Physical activity at age 12 and adult breast cancer risk (United States).” Cancer Causes Control 10, no. 4 (August 1999): 293–302. https://doi.org/10.1023/a:1008971417282.Full Text Link to Item
-
Furberg, H., B. Newman, P. Moorman, and R. Millikan. “Lactation and breast cancer risk.” Int J Epidemiol 28, no. 3 (June 1999): 396–402. https://doi.org/10.1093/ije/28.3.396.Full Text Link to Item
-
Moorman, P. G., B. Newman, R. C. Millikan, C. K. Tse, and D. P. Sandler. “Participation rates in a case-control study: the impact of age, race, and race of interviewer.” Ann Epidemiol 9, no. 3 (April 1999): 188–95. https://doi.org/10.1016/s1047-2797(98)00057-x.Full Text Link to Item
-
Millikan, R. C., G. S. Pittman, C. K. Tse, E. Duell, B. Newman, D. Savitz, P. G. Moorman, R. J. Boissy, and D. A. Bell. “Catechol-O-methyltransferase and breast cancer risk.” Carcinogenesis 19, no. 11 (November 1998): 1943–47. https://doi.org/10.1093/carcin/19.11.1943.Full Text Link to Item
-
Rockhill, B., P. G. Moorman, and B. Newman. “Age at menarche, time to regular cycling, and breast cancer (North Carolina, United States).” Cancer Causes Control 9, no. 4 (August 1998): 447–53. https://doi.org/10.1023/a:1008832004211.Full Text Link to Item
-
Moorman, P. G., B. S. Hulka, R. A. Hiatt, N. Krieger, B. Newman, J. H. Vogelman, and N. Orentreich. “Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.” Cancer Epidemiol Biomarkers Prev 7, no. 6 (June 1998): 483–88.Link to Item
-
Millikan, R. C., G. S. Pittman, B. Newman, C. K. Tse, O. Selmin, B. Rockhill, D. Savitz, P. G. Moorman, and D. A. Bell. “Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.” Cancer Epidemiol Biomarkers Prev 7, no. 5 (May 1998): 371–78.Link to Item
-
Newman, B., H. Mu, L. M. Butler, R. C. Millikan, P. G. Moorman, and M. C. King. “Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.” Jama 279, no. 12 (March 25, 1998): 915–21. https://doi.org/10.1001/jama.279.12.915.Full Text Link to Item
-
Aldrich, T. E., D. Vann, P. G. Moorman, and B. Newman. “Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry.” Breast Cancer Res Treat 35, no. 1 (July 1995): 61–64. https://doi.org/10.1007/BF00694746.Full Text Link to Item
-
Newman, B., P. G. Moorman, R. Millikan, B. F. Qaqish, J. Geradts, T. E. Aldrich, and E. T. Liu. “The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology.” Breast Cancer Res Treat 35, no. 1 (July 1995): 51–60. https://doi.org/10.1007/BF00694745.Full Text Link to Item
-
Moorman, P. G., and B. S. Hulka. “Menopausal hormones and the risk of breast cancer.” Endocrinologist 2, no. 3 (January 1, 1992): 189–94. https://doi.org/10.1097/00019616-199205000-00009.Full Text
-
Moorman, P. G., C. G. Hames, and H. A. Tyroler. “Socioeconomic status and morbidity and mortality in hypertensive blacks.” Cardiovasc Clin 21, no. 3 (1991): 179–94.Link to Item
-
Wils, J. A. “Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide. Gynecologic Oncology Group of the Comprehensive Cancer Center.” Oncology 47, no. 2 (1990): 115–20. https://doi.org/10.1159/000226801.Full Text Link to Item
-
-
Other Articles
-
Melcher, B. Q., P. Morgan, L. Lin, J. Stem, P. Moorman, and A. Stouder. “Satisfaction guaranteed? An analysis of lecturer characteristics associated with physician assistant student satisfaction.” The Journal of Physician Assistant Education : The Official Journal of the Physician Assistant Education Association, 2012.
-
-
Conference Papers
-
Harris, Holly R., Kristin A. Guertin, Tareq F. Camacho, Courtney E. Johnson, Anna H. Wu, Patricia G. Moorman, Evan Myers, et al. “Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium.” In Int J Cancer, 151:1228–39, 2022. https://doi.org/10.1002/ijc.34141.Full Text Link to Item
-
Peres, Lauren C., Christelle Colin-Leitzinger, Sweta Sinha, Jeffrey R. Marks, Jose R. Conejo-Garcia, Anthony J. Alberg, Elisa V. Bandera, et al. “Abstract PO-232: Racial differences in the tumor immune landscape and survival of high-grade serous ovarian carcinoma.” In Cancer Epidemiology, Biomarkers &Amp; Prevention, Vol. 31. American Association for Cancer Research (AACR), 2022. https://doi.org/10.1158/1538-7755.disp21-po-232.Full Text
-
Staples, J. N., L. C. Peres, F. Camacho, A. J. Alberg, E. Bandera, J. Barnholtz-Sloan, M. L. Bondy, et al. “Assessing the impact of cardiometabolic risk on ovarian cancer survival among African-American women in the African-American cancer epidemiology study (AACES).” In Gynecologic Oncology, 159:157–58. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.05.226.Full Text
-
Peres, Lauren C., Tareq F. Camacho, Elisa V. Bandera, Traci N. Bethea, Charlotte E. Joslin, Anna H. Wu, Alicia Beeghly-Fadiel, et al. “Abstract 1180: Estimating the contribution of epidemiologic risk factors to racial differences in epithelial ovarian cancer incidence.” In Cancer Research, 80:1180–1180. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7445.am2020-1180.Full Text
-
Peres, Lauren C., James R. Hebert, Bo Qin, Kristin A. Guertin, Elisa V. Bandera, Nitin Shivappa, Tareq F. Camacho, et al. “Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma.” In Cancer Epidemiology Biomarkers & Prevention, Vol. 29, 2020.Link to Item
-
Bandera, Elisa V., Fabian Camacho, Deanna Chyn, Emily K. Cloyd, Traci N. Bethea, Alicia Beeghly-Fadiel, Charlotte E. Joslin, et al. “Abstract C070: Racial disparities in body mass index and ovarian cancer risk in the OCWAA Consortium.” In Cancer Epidemiology, Biomarkers &Amp; Prevention, 29:C070–C070. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp19-c070.Full Text
-
Bethea, Traci N., Heather M. Ochs-Balcom, Elisa V. Bandera, Alicia Beeghly-Fadiel, Fabian Camancho, Emily K. Cloyd, Holly R. Harris, et al. “Abstract C038: First- and second-degree family history of ovarian and breast cancers in relation to risk of invasive ovarian cancer in African American and White women.” In Cancer Epidemiology, Biomarkers &Amp; Prevention, 29:C038–C038. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp19-c038.Full Text
-
Peres, Lauren C., James R. Hebert, Bo Qin, Kristin A. Guertin, Elisa V. Bandera, Nitin Shivappa, Tareq F. Camacho, et al. “Abstract C044: Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma.” In Cancer Epidemiology, Biomarkers &Amp; Prevention, 29:C044–C044. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp18-c044.Full Text
-
Peres, Lauren C., James R. Hebert, Bo Qin, Kristin A. Guertin, Elisa V. Bandera, Nitin Shivappa, Tareq F. Camacho, et al. “Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma.” In Cancer Epidemiology Biomarkers & Prevention, Vol. 29, 2020.Link to Item
-
Wang, Tengteng, Patrick B. Bradshaw, Sarah J. Nyante, Hazel B. Nichols, Patricia G. Moorman, Geoffrey C. Kabat, Susan L. Teitelbaum, Alfred I. Neugut, and Marilie D. Gammon. “Abstract 3294: Urinary estrogen metabolites and long-term all-cause and cause-specific mortality following breast cancer diagnosis: A population-based study.” In Epidemiology. American Association for Cancer Research, 2019. https://doi.org/10.1158/1538-7445.sabcs18-3294.Full Text
-
Staples, J. N., L. C. Peres, F. Camacho, A. J. Alberg, E. Bandera, J. Barnholtz-Sloan, M. L. Bondy, et al. “Cardiovascular comorbidities and risk of ovarian carcinoma among African American women in the African American cancer epidemiology study (AACES).” In Gynecologic Oncology, 154:123–123. Elsevier BV, 2019. https://doi.org/10.1016/j.ygyno.2019.04.293.Full Text
-
Mullins, Megan, Michele L. Cote, Sarah Abbott, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, et al. “Determinants of delays in care-seeking for ovarian cancer symptoms in African American women.” In Cancer Epidemiology Biomarkers & Prevention, 27:167–68. AMER ASSOC CANCER RESEARCH, 2018.Link to Item
-
Salas, Lucas A., Lauren C. Peres, Sarah E. Abbott, Casey S. Greene, Jeffrey R. Marks, Anthony J. Alberg, Elisa V. Bandera, et al. “Abstract 5318: High-grade serous ovarian cancer DNA methylation and survival in African-American women.” In Cancer Research, 78:5318–5318. American Association for Cancer Research (AACR), 2018. https://doi.org/10.1158/1538-7445.am2018-5318.Full Text
-
Qin, Bo, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Abstract B51: Dairy, calcium, vitamin D and ovarian cancer risk in African-American women.” In Cancer Epidemiology, Biomarkers &Amp; Prevention, 26:B51–B51. American Association for Cancer Research (AACR), 2017. https://doi.org/10.1158/1538-7755.disp16-b51.Full Text
-
Doherty, Jennifer A., Casey S. Greene, James E. Rudd, Laura J. Tafe, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, et al. “Abstract 3407: Gene expression subtypes of high grade serous ovarian cancer in African American women.” In Cancer Research, 76:3407–3407. American Association for Cancer Research (AACR), 2016. https://doi.org/10.1158/1538-7445.am2016-3407.Full Text
-
Peres, Lauren C., Sarah E. Abbott, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, et al. “Abstract 1754: Body powder use and ovarian cancer: the African American Cancer Epidemiology Study.” In Cancer Research, 76:1754–1754. American Association for Cancer Research (AACR), 2016. https://doi.org/10.1158/1538-7445.am2016-1754.Full Text
-
Bandera, Elisa V., Bo Qin, Anthony J. Alberg, Jill Barnholtz-Sloan, Melissa Bondy, Michelle Cote, Ellen Funkhouser, et al. “Abstract A73: Obesity, weight gain, and ovarian cancer risk in African American women.” In Cancer Epidemiology, Biomarkers &Amp; Prevention, 25:A73–A73. American Association for Cancer Research (AACR), 2016. https://doi.org/10.1158/1538-7755.disp15-a73.Full Text
-
Qin, Bo, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, et al. “Abstract PR05: Dietary quality and ovarian cancer risk in African American women.” In Cancer Epidemiology, Biomarkers &Amp; Prevention, 25:PR05–PR05. American Association for Cancer Research (AACR), 2016. https://doi.org/10.1158/1538-7755.disp15-pr05.Full Text
-
Gaines, Alexis R., Elizabeth L. Turner, Patricia G. Moorman, Stephen J. Freedland, Christopher J. Keto, Megan E. McPhail, Delores J. Grant, Adriana C. Vidal, and Cathrine Hoyo. “The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.” In Cancer Causes Control, 25:1029–35, 2014. https://doi.org/10.1007/s10552-014-0402-6.Full Text Link to Item
-
Moorman, P. G., J. M. Schildkraut, E. R. Myers, E. S. Iversen, N. Warren-White, and F. Wang. “Weight gain after pre-menopausal hysterectomy.” In American Journal of Epidemiology, 167:S32–S32. OXFORD UNIV PRESS INC, 2008.Link to Item
-
Shantakumar, Sumitra, Mary Beth Terry, Andrea Paykin, Susan L. Teitelbaum, Julie A. Britton, Patricia G. Moorman, Stephen B. Kritchevsky, Alfred I. Neugut, and Marilie D. Gammon. “Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.” In Cancer Research, Vol. 66. AMER ASSOC CANCER RESEARCH, 2006.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.